Introduction: GEP-NETs are malignant entities poorly understood still, deserving important attention for a better management of the disease.
Aim(s): To describe the clinical features and management of metastatic GEP-NETs patients in a reference oncology university hospital.
Materials and methods: Retrospective study including patients with GEP-NETs from the daily clinical practice in 2009. Data was provided from the Pathology Department, achieving positivity for chromogranin A (CGA) 75%, synaptophysin 96% and enolase 48%.
Conference: 10th Annual ENETS Conference 2013 (2013)
Category: Medical treatment – Chemotherapy, medical treatment - others
Presenting Author: Msc MD María Del Pilar Solis-Hernandez
Solís M P
, Fonseca P J
, Faez L
, Álvarez C
, Pérez Q
, Rodríguez D
, Ruiz L
, Li W
, Sánchez L
, Izquierdo M
, Menéndez M D
, Vieitez J M
To read results and conclusion, please login ...
Further abstracts you may be interested in